These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20631033)

  • 21. Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging.
    Berman DS; Kang X; Tamarappoo B; Wolak A; Hayes SW; Nakazato R; Thomson LE; Kite F; Cohen I; Slomka PJ; Einstein AJ; Friedman JD
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):273-82. PubMed ID: 19356571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incremental value of coronary artery calcium score in predicting long-term prognosis and defining the warranty period of normal adenosine stress-only myocardial perfusion imaging using CZT SPECT.
    Kamerman M; van Dijk JD; Timmer JR; Ottervanger JP; Knollema S; Jager PL; Mouden M
    J Nucl Cardiol; 2023 Dec; 30(6):2692-2701. PubMed ID: 37592058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
    Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
    Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
    Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
    Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary arteriography in the diagnosis results and prognosis analysis of suspected coronary artery disease in patients with normal SPET myocardial perfusion imaging.
    Yuan JW; Wang YT; Lu CZ
    Hell J Nucl Med; 2015; 18(3):215-21. PubMed ID: 26637500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine myocardial SPECT--its efficacy and safety and correlation with coronary angiogram.
    Shelley S; Sathyamurthy I; Madhavan ; Subramanyan K; Najeeb OM; Ramachandran P
    J Assoc Physicians India; 2003 Jun; 51():557-60. PubMed ID: 15266920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease.
    Hurrell DG; Milavetz J; Hodge DO; Gibbons RJ
    Am Heart J; 2000 Jul; 140(1):61-6. PubMed ID: 10874264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year prognosis of patients with normal myocardial perfusion imaging using technitium-99m sestamibi in suspected coronary artery disease: a single-center experience of 1,047 patients.
    Raziei G; Tavakoli A; Seifollahi Asl S; Amoiei M; Javadi H; Assadi M
    Perfusion; 2011 Jul; 26(4):309-14. PubMed ID: 21508085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia.
    Hachamovitch R; Berman DS; Kiat H; Cohen I; Lewin H; Amanullah A; Kang X; Friedman J; Diamond GA
    Am J Cardiol; 1997 Aug; 80(4):426-33. PubMed ID: 9285653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease.
    Boyne TS; Koplan BA; Parsons WJ; Smith WH; Watson DD; Beller GA
    Am J Cardiol; 1997 Feb; 79(3):270-4. PubMed ID: 9036743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.
    Hachamovitch R; Rozanski A; Shaw LJ; Stone GW; Thomson LE; Friedman JD; Hayes SW; Cohen I; Germano G; Berman DS
    Eur Heart J; 2011 Apr; 32(8):1012-24. PubMed ID: 21258084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography.
    Amanullah AM; Berman DS; Kang X; Cohen I; Germano G; Friedman JD
    Am Heart J; 2000 Sep; 140(3):456-62. PubMed ID: 10966548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-speed myocardial perfusion imaging initial clinical comparison with conventional dual detector anger camera imaging.
    Sharir T; Ben-Haim S; Merzon K; Prochorov V; Dickman D; Ben-Haim S; Berman DS
    JACC Cardiovasc Imaging; 2008 Mar; 1(2):156-63. PubMed ID: 19356422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.
    Heller GV; Herman SD; Travin MI; Baron JI; Santos-Ocampo C; McClellan JR
    J Am Coll Cardiol; 1995 Nov; 26(5):1202-8. PubMed ID: 7594033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests.
    Schinkel AF; Bax JJ; Elhendy A; van Domburg RT; Valkema R; Vourvouri E; Bountioukos M; Rizzello V; Biagini E; Agricola E; Krenning EP; Simoons ML; Poldermans D
    Am J Med; 2004 Jul; 117(1):1-9. PubMed ID: 15210381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of combined perfusion and function by stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging in patients with suspected or known coronary artery disease.
    Petix NR; Sestini S; Coppola A; Marcucci G; Nassi F; Taiti A; Guarnaccia V; Mennuti A; Mazzoni V; Zipoli A
    Am J Cardiol; 2005 Jun; 95(11):1351-7. PubMed ID: 15904642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of cardiac events in patients having left bundle-branch block with/without chest pain using dipyridamole technetium-99m-sestamibi myocardial perfusion imaging.
    Usmani S; Khan HA; Zaman MU; Niyaz K
    Med Princ Pract; 2009; 18(4):310-6. PubMed ID: 19494540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.